Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives

Autor: Emilie Thivat, Xavier Durando, Anne Sinsard, Michel D'Incan, Philippe Chollet, Jean-Claude Madelmont

Publikováno v: BMC Cancer
BMC Cancer, BioMed Central, 2005, 5, pp.147. ⟨10.1186/1471-2407-5-147⟩
BMC Cancer, Vol 5, Iss 1, p 147 (2005)

Background Median survival of metastatic malignant melanoma is 6.0 to 7.5 months, with a 5-year survival of ~6.0%. Although long-term complete remissions are rare, few reports describe cases after chemotherapy. Fifty-three patients with metastatic me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43310885b46ca755a5c83da7f4f3cbcf